DEA schedule
Is dexmethylphenidate a controlled substance?
Federal schedule for dexmethylphenidate from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Dexmethylphenidate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted dexmethylphenidate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 114 prescription listings from 15 labelers, all Schedule II |
| DEA controlled substances list | Methylphenidate: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Methylphenidate | 1724 | II | No | Concerta; Ritalin; Methylin | Isomer or salt of the listed substance (21 CFR 1308) |
Dexmethylphenidate NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0078-0431 | Focalin XR | capsule, extended release | 10 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-236 | Focalin XR | capsule, extended release | 10 mg/1 | Sandoz Inc | CII |
| 0078-0493 | Focalin XR | capsule, extended release | 15 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-237 | Focalin XR | capsule, extended release | 15 mg/1 | Sandoz Inc | CII |
| 0078-0432 | Focalin XR | capsule, extended release | 20 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-238 | Focalin XR | capsule, extended release | 20 mg/1 | Sandoz Inc | CII |
| 0078-0608 | Focalin XR | capsule, extended release | 25 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-239 | Focalin XR | capsule, extended release | 25 mg/1 | Sandoz Inc | CII |
| 0078-0433 | Focalin XR | capsule, extended release | 30 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-240 | Focalin XR | capsule, extended release | 30 mg/1 | Sandoz Inc | CII |
| 0078-0609 | Focalin XR | capsule, extended release | 35 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-241 | Focalin XR | capsule, extended release | 35 mg/1 | Sandoz Inc | CII |
| 0078-0434 | Focalin XR | capsule, extended release | 40 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-242 | Focalin XR | capsule, extended release | 40 mg/1 | Sandoz Inc | CII |
| 0078-0430 | Focalin XR | capsule, extended release | 5 mg/1 | Novartis Pharmaceuticals Corporation | CII |
| 66758-235 | Focalin XR | capsule, extended release | 5 mg/1 | Sandoz Inc | CII |
| 66758-252 | Focalin | tablet | 10 mg/1 | Sandoz Inc | CII |
| 66758-250 | Focalin | tablet | 2.5 mg/1 | Sandoz Inc | CII |
| 66758-251 | Focalin | tablet | 5 mg/1 | Sandoz Inc | CII |
| 0093-5551 | Dexmethylphenidate Hydrochloride | capsule, extended release | 10 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 0115-9919 | Dexmethylphenidate hydrochloride | capsule, extended release | 10 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0527-8107 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 10 mg/1 | Lannett Company, Inc. | CII |
| 0781-2728 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 10 mg/1 | Sandoz Inc | CII |
| 31722-230 | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release | 10 mg/1 | Camber Pharmaceuticals, Inc. | CII |
| 49884-049 | Dexmethylphenidate Hydrochloride | capsule, extended release | 10 mg/1 | Par Health USA, LLC | CII |
| 63629-2171 | Dexmethylphenidate Hydrochloride | capsule, extended release | 10 mg/1 | Bryant Ranch Prepack | CII |
| 70010-005 | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release | 10 mg/1 | Granules Pharmaceuticals Inc. | CII |
| 72162-1473 | Dexmethylphenidate Hydrochloride | capsule, extended release | 10 mg/1 | Bryant Ranch Prepack | CII |
| 0093-5552 | Dexmethylphenidate Hydrochloride | capsule, extended release | 15 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 0115-9920 | Dexmethylphenidate hydrochloride | capsule, extended release | 15 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0527-8108 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 15 mg/1 | Lannett Company, Inc. | CII |
| 0781-2729 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 15 mg/1 | Sandoz Inc | CII |
| 31722-231 | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release | 15 mg/1 | Camber Pharmaceuticals, Inc. | CII |
| 49884-428 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 15 mg/1 | Par Health USA, LLC | CII |
| 63629-2172 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 15 mg/1 | Bryant Ranch Prepack | CII |
| 70010-006 | DEXMETHYLPHENIDATE HYDROCHLORIDE | capsule, extended release | 15 mg/1 | Granules Pharmaceuticals Inc. | CII |
| 72162-1502 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 15 mg/1 | Bryant Ranch Prepack | CII |
| 0093-5553 | Dexmethylphenidate Hydrochloride | capsule, extended release | 20 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 0115-9921 | Dexmethylphenidate hydrochloride | capsule, extended release | 20 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0527-8109 | Dexmethylphenidate Hydrochloride Extended-Release | capsule, extended release | 20 mg/1 | Lannett Company, Inc. | CII |
Showing 40 of 114 listings.
Questions
Is dexmethylphenidate a controlled substance?
Yes. Dexmethylphenidate is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Methylphenidate (Schedule II).
Is dexmethylphenidate a narcotic?
No. The DEA list does not mark dexmethylphenidate as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is dexmethylphenidate?
Dexmethylphenidate is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Dexmethylphenidate
- What is Dexmethylphenidate used for?FDA label uses
- Generic for Focalin XRFDA Orange Book
- Generic for FocalinFDA Orange Book
- What is Focalin used for?FDA label uses
- Is Focalin a controlled substance?Schedule II
- Central Nervous System Stimulants listFDA drug class
- NDC 0078-0430Dexmethylphenidate NDC record
- NDC 0078-0431Dexmethylphenidate NDC record
- NDC 0078-0432Dexmethylphenidate NDC record
- Schedule II drugs listDEA schedule